Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Title
Intervention Indication Therapeutic Area Year Actions
Ranibizumab for proliferative and non-proliferative diabetic retinopathy Ranibizumab (Lucentis Port Delivery System; Lucentis) Diabetic retinopathy Endocrine Nutritional and Metabolic Disorders , Ophthalmology 2018 View  |  Download
Ranibizumab for Retinopathy of Prematurity – first line Ranibizumab (Lucentis Port Delivery System; Lucentis) Retinopathy of prematurity Gynaecology and Obstetrics , Ophthalmology 2018 View  |  Download
Ranibizumab port delivery system for the treatment of age-related macular degeneration Ranibizumab (Lucentis Port Delivery System; Lucentis) Age-related macular degeneration (AMD) Ophthalmology 2020 View  |  Download
Ranibizumab port delivery system for treating
diabetic macular oedema
Ranibizumab (Lucentis Port Delivery System; Lucentis) Diabetic macular oedema Endocrine Nutritional and Metabolic Disorders , Ophthalmology 2022 View  |  Download
Ravulizumab (subcutaneous formulation) for treating paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome Ravulizumab (ALXN1210; Ultomiris) Atypical haemolytic uraemic syndrome (aHUS) , Paroxysmal nocturnal haemoglobinuria (PNH) Haematology , Nephrology 2022 View  |  Download
Ravulizumab for atypical haemolytic uraemic syndrome in adults and children – first line Ravulizumab (ALXN1210; Ultomiris) Atypical haemolytic uraemic syndrome (aHUS) Haematology , Nephrology 2018 View  |  Download
Ravulizumab for paroxysmal nocturnal haemoglobinuria in paediatrics Ravulizumab (ALXN1210; Ultomiris) Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2021 View  |  Download
Ravulizumab for treating generalised myasthenia gravis Ravulizumab (ALXN1210; Ultomiris) Myasthenia gravis (MG) Musculoskeletal System 2021 View  |  Download
Ravulizumab for treating thrombotic microangiopathies following haematopoietic stem cell transplantation in children Ravulizumab (ALXN1210; Ultomiris) Thrombotic microangiopathies Haematology 2023 View  |  Download
Ravulizumab for treatment of neuromyelitis optica spectrum disorder Ravulizumab (ALXN1210; Ultomiris) Neuromyelitis optica spectrum disorders Nephrology , Ophthalmology 2022 View  |  Download
1 2 85 86 87 88 89 117 118
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications